Novel strategy to produce SARS-CoV-2 nucleocapsid protein for serological testing – News-Medical.net

The production of the nucleocapsid (N) and spike (S) proteins for diagnostic testing to confirm the presence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is both costly and time-consuming. However, new research published on the preprint…

Click here to view the original article.